SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about press release

08 Feb 2021 Evaluate
Medicamen Biotech has informed that it has enclosed Newpaper Advertisement for Intimation of Board Meeting to be held on 12.02.2021 at 1506, Chiranjiv Towers 43, Nehru Palace, New Delhi- 110019 published in the Financial Express, and Jansatta dated February 6, 2021.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

268.30 9.80 (3.79%)
20-Apr-2026 15:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1667.00
Dr. Reddys Lab 1230.30
Cipla 1228.30
Zydus Lifesciences 936.80
Lupin 2326.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×